MAPS submitted the MDMA/PTSD protocol for review to the Independent Review Consulting Institutional Review Board (IRC-IRB), with the protocol to be discussed by the review board on January 2, 2003. Officials …
On November 20, after the Western IRB decided not to review MAPS’ MDMA/PTSD protocol, Rick Doblin spoke to James Baldwin, Ph.D., Executive Director of the Western IRB. Dr. Baldwin informed Rick that …
MAPS sent a draft of the MDMA/PTSD pilot study that MAPS is seeking to sponsor in Israel to Dr. Moshe Kotler and Dr. Jorge Gleser, Israeli Ministry of Health, for their review. MAPS’ conference on …
Ron Warren, Senior Vice President of the Western IRB, wrote a letter to Dr. Michael Mithoefer, reporting the outcome of the November 19 meeting of the WIRB’s Executive Policy Committee. The WIRB …
MAPS submitted a short letter to the Western IRB’s Executive Policy Committee, in advance of its November 19 meeting at which it will discuss its review of MAPS’ MDMA/PTSD protocol. The letter …
Dr. Donald Abrams and Dr. Ethan Russo report on their medical marijuana research at the Marijuana Policy Project (MPP)/Students for a Sensible Drug Policy (SSDP) conference in Anaheim, California. View …
This article by Time magazine discusses the potential risks and benefits of marijuana. Is Pot Good For You? Well, no. But the latest research suggests the health risk from occasional use is mild, and it …
After reviewing MAPS’ letter, Dr. James Baldwin of the WIRB informed Rick Doblin that the October 30 meeting was canceled, but not for the reasons MAPS had hoped. Dr. James Baldwin said that the …
MAPS submitted a lengthy written response to the WIRB letter, along with 14 letters of information and support from MDMA scientists around the world. MAPS’ letter addressed every point raised in …
Rick Doblin speaks with James Baldwin, Ph.D., Executive Director of the WIRB. Dr. Baldwin apologized for the tone of the WIRB letter and seemed to view favorably MAPS’ arguments. He was informed …
Dr. George Ricaurte publishes an article in Science reporting on primate data that he claims suggests that even one night’s recreational use of Ecstasy can lead to Parkinson’s. This government-funded …
John Mendelson, M.D., Associate Professor at University California San Francisco, commented on Michael Mithoefer, M.D.s proposed MDMA study. Mendelson states that the risk of heart valve changes after …
